CTD Dossier for Swissmedic and the Swiss Module 1

3 minLast updated: Back to the hub

Short answer

Swissmedic uses the Common Technical Document with five modules. Modules 2 to 5 can be adopted from the EU or US dossier. Module 1 is Switzerland-specific and contains the forms, the trilingual medicinal product information, packaging drafts and proof of Swiss domicile.

How are the five modules structured?

Module 1 is regional and therefore Switzerland-specific. Module 2 contains the summaries and overviews, Module 3 the quality data on the active substance and finished product, Module 4 the preclinical reports, and Module 5 the clinical study reports. Only Module 1 has to be newly prepared for Switzerland.

Structure of the CTD for a Swiss application
ModuleContentSwitzerland-specific
1Forms, medicinal product information, pack texts, proof of domicile, licencesyes, fully
2Quality Overall Summary, Nonclinical and Clinical Overview and Summariesno, wording adjustments possible
3Active substance, finished product, specifications, stability, GMP evidenceno
4Pharmacology, pharmacokinetics, toxicologyno
5Clinical study reports, study lists, literatureno

What belongs in the Swiss Module 1?

Module 1 requires the current Swissmedic forms, the prescribing information and patient information in German, French and Italian, packaging drafts with all mandatory particulars, proof of domicile and licences, and details on pharmacovigilance and the risk management plan.

  • Application forms in the current version, complete and signed.
  • Prescribing information and patient information in German, French and Italian.
  • Packaging drafts for every pack presentation, with authorisation number, dispensing category and batch details.
  • Commercial register extract for the future marketing authorisation holder.
  • Manufacturing, import or wholesale dealing licence, GMP certificates for the manufacturing sites.
  • Details of the person responsible for pharmacovigilance and the risk management plan.
  • For Art. 13 TPA: foreign decisions, assessment reports and a deviation table.

How do you plan the trilingual medicinal product information?

The German version is finalised first, since the assessment is generally conducted against it. French and Italian follow as checked translations. After every round of questions, all three versions must be updated in sync; this needs version management that reconciles changes across languages.

  1. Align the German version with the current Swissmedic template, not the EU SmPC layout.
  2. Cross-check technical terminology against the prescribing information of comparable products authorised in Switzerland.
  3. Have the French and Italian versions prepared by specialist-trained translators.
  4. Manage all three versions with a change log that links corresponding passages.
  5. After every round of questions, update and proofread all languages at the same time.
  6. After authorisation, publish the approved versions via AIPS.

What technical format requirements apply?

Swissmedic accepts eCTD and works via the Swissmedic Portal. What matters is correct sequence numbering, valid lifecycle operations, searchable PDFs without password protection, and compliance with file-naming and folder conventions. Validation errors lead to extended deadlines during formal review.

Frequently asked questions

  • Can I use the EU Module 1?

    No. The EU Module 1 has a different structure and different forms. Modules 2 to 5, however, you can adopt unchanged in content.

  • Must the patient information be available in all three languages?

    Yes. The prescribing information and patient information must be submitted in German, French and Italian. The package leaflet must be available in the languages in which the product is distributed, but at least in the three official languages.

  • Is eCTD mandatory?

    For most procedures, electronic submission via the Portal is the standard. eCTD is the preferred format; any deviation must be clarified with Swissmedic in advance.

  • How long does the dossier remain lifecycle-capable?

    For the entire lifetime of the authorisation. Every variation is submitted as a new sequence, which makes a clean sequence history over the years mandatory.

Sources

Last updated:

Read next

Planning an authorisation or a licence?

Describe your question or support needs. Your enquiry reaches the website operator. Specialist services are delivered by separately appointed providers; forwarding requires your consent.

  • Independent publishing
  • Public sources
  • Swiss market focus
  • Eight website languages
Send an enquiry
Does this apply to your product?Send an enquiry

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissregulatoryguide.com